Arucas Granule 4 mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Prescription medication
Ari Pharmaceuticals Co., Ltd.
MFDS item code 201908599 · Approved 2019.12.24
Prevention and maintenance treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication helps prevent asthma and manage symptoms in the long term when they persist. It is also effective in relieving various symptoms of seasonal and perennial allergic rhinitis. Therefore, it is used for continuous treatment in patients with asthma and allergic rhinitis.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 packet once daily in the evening. This 4 mg granule formulation may be taken directly by mouth or mixed with a small amount (approximately 5 mL) of soft food at room temperature or colder, such as infant food, breast milk, or porridge. Do not open the package until immediately before taking the dose. Once opened, immediately (within 15 minutes) mix it with infant food, breast milk, or food, or take the entire dose directly. Do not leave this medicine mixed with infant food, breast milk, or food for an extended period; discard any remainder. This formulation is not intended to be mixed with beverages other than infant food or breast milk, but it is acceptable to drink a beverage immediately after taking it. This medicine may be taken without regard to meals.
Children aged 2~5 years: Administer montelukast 4 mg orally once daily. Infants aged 12 months~under 2 years: Administer this medicine 4 mg orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Children aged 2~5 years: Administer montelukast 4 mg orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants aged 6 months~under 2 years: Administer this medicine 4mg orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication is used to prevent and treat asthma and allergic rhinitis. During treatment, significant neuropsychiatric symptoms may occur, so patients and caregivers should closely observe any changes in behavior or mental state such as anxiety, agitation, depression, hallucinations, or suicidal thoughts. If these symptoms occur, discontinue use immediately and consult a doctor, with continuous management needed until symptoms improve. Do not take this medication if you have a hypersensitivity to it or its components. Diverse adverse reactions such as fatigue, headache, dyspepsia, rash, nasal congestion, and cough may occur after taking it, and while safety has been evaluated in both children and adults, caution for adverse reactions is required. This medication is not for use during acute asthma attacks, so for acute symptoms, a rapid-acting inhaled bronchodilator should be used, and this medication should be taken consistently as directed by a physician. Patients with hypersensitivity to aspirin should avoid aspirin or non-steroidal anti-inflammatory drugs while taking this medication. It should only be used during pregnancy if absolutely necessary, and nursing mothers should use it with caution. No significant interactions have been reported when using this medication with other asthma treatments or multiple drugs, but it should be used according to a doctor’s guidance when taken with certain medications. There is no specific antidote for overdose, so symptomatic treatment should be provided under medical supervision. This medication is sensitive to light, so do not open the packaging until just before use, and it is advisable to take it immediately after opening. Keep it out of the reach of children, and be cautious as transferring it to another container may change its quality. Consult a doctor if asthma symptoms worsen, or persist during treatment, and do not arbitrarily discontinue use or adjust dosages of other medications.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air, moisture, and light. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will maintain the medication's efficacy for a longer period.
A homogeneous and white granule without foreign matter
4 mg/packet [4 mg/packet x 28]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Prescription medication
Ari Pharmaceuticals Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.